A detailed history of Provenance Wealth Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Provenance Wealth Advisors, LLC holds 300 shares of HLN stock, worth $2,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 417 28.06%
Holding current value
$2,877
Previous $4.29 Million 37.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$8.72 - $10.35 $1,020 - $1,210
-117 Reduced 28.06%
300 $2.69 Million
Q2 2024

Aug 15, 2025

SELL
$8.01 - $8.64 $3,444 - $3,715
-430 Reduced 50.77%
417 $3.44 Million
Q4 2023

Aug 15, 2025

BUY
$7.78 - $8.62 $4,255 - $4,715
547 Added 182.33%
847 $6.97 Million
Q3 2023

Aug 15, 2025

BUY
$7.85 - $8.94 $2,355 - $2,682
300 New
300 $2.5 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Provenance Wealth Advisors, LLC Portfolio

Follow Provenance Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provenance Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Provenance Wealth Advisors, LLC with notifications on news.